Abstract:The importance of epigenetic alterations in degenerative diseases remains unclear. We herein report that arachidonic acid ester 12 lipoxygenase (ALOX12) and cystathionine beta-synthase (CBS) are hypermethylated in both a rat model of osteoporosis and human patients with osteoporosis. Bisulfite conversion and qMSP analyses revealed the methylation status of ALOX12 and CBS. By performing ovariectomy in rats, we successfully induced osteoporosis that was associated with a decreased bone mineral density and trabecular number. DNA hypermethylation of both ALOX12 and CBS were detected in the osteoporotic rats. They also had decreased protein expression of both targets. The hypermethylation of ALOX12 was confirmed in both whole blood and bone marrow samples from patients with osteoporosis. Our results demonstrate that there are specific epigenetic modifications present in individuals with osteoporosis that might serve as an early diagnostic biomarker in the future.Funding Information: This work is supported by grants from the Interdisciplinary Program of Shanghai Jiao Tong University (No: YG2019QNA23).Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: The study was approved by the ethics committees of Shanghai Sixth People’s Hospital Affiliated with Shanghai Jiao Tong University (Shanghai, China) (No. 2021-YS-093). The whole blood and bone marrow samples are acquired in every participant. Clinical information including the gender, age, smoking history, history of hypertension, history of diabetes, etc., was obtained from the medical records. Sprague Dawley rats were purchased from the Shanghai Laboratory Animal Center (Shanghai, China). Age- and sex-matched rats were fed and maintained under specific pathogen-free conditions following the criteria of the National Institutes of Health (Bethesda, MD) Guide for the Care and Use of Laboratory Animals with the approval of the ethics committees of Shanghai Sixth People’s Hospital Affiliated with Shanghai Jiao Tong University (Shanghai, China) (NO 2022-0271).

Methylation of Bone SOST Impairs SP7, RUNX2, and ERα Transactivation in Patients with Postmenopausal Osteoporosis.

Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene

M6a Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells.

Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis

Hypermethylation Within the <i>alox12</i> and <i>cbs</i> Promoters in a Rat Model of Osteoporosis and Human Osteoporosis Patients: Potential Biomarkers for an Early Diagnosis

Alterations in DNA methylation profiles in cancellous bone of postmenopausal women with osteoporosis

SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation

METTL3-mediated m6A modification of SOX4 regulates osteoblast proliferation and differentiation via YTHDF3 recognition

The miR-665/SOST Axis Regulates the Phenotypes of Bone Marrow Mesenchymal Stem Cells and Osteoporotic Symptoms in Female Mice

Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1

Mechanisms of estrogen deficiency-induced osteoporosis based on transcriptome and DNA methylation

Targeting Sulfation-Dependent Mechanoreciprocity Between Matrix and Osteoblasts to Mitigate Bone Loss.

Silencing Proteasome 26S Subunit ATPase 2 (PSMC2) Protects the Osteogenic Differentiation In Vitro and Osteogenesis In Vivo

Hypermethylation of Bmp2 and Fgfr2 Promoter Regions in Bone Marrow Mesenchymal Stem Cells Leads to Bone Loss in Prematurely Aged Mice.

Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis

miR4352b a cross-species modulator of SOSTDC1, targets dual pathway to regulate bone health and fracture healing

METTL14-mediated methylation of SLC25A3 mitigates mitochondrial damage in osteoblasts, leading to the improvement of osteoporosis

Oxidative Stress-Induced Hypermethylation of KLF5 Promoter Mediated by DNMT3B Impairs Osteogenesis by Diminishing the Interaction with Β-Catenin.

SOST Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Osteoporosis.

METTL3-mediated LINC00657 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Via Mir-144-3p/bmpr1b Axis

Epitranscriptomic Regulation of Osteoblast Function: Unveiling the Role of METTL3 and the m6A/YTHDF3/SOX4 Signaling Axis